Skip Navigation



JAC Advance Access published online on May 9, 2007

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm129
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
60/1/78    most recent
dkm129v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Landman, D.
Right arrow Articles by Quale, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landman, D.
Right arrow Articles by Quale, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY

David Landman1, Simona Bratu1, Sandeep Kochar1, Monica Panwar1, Manoj Trehan1, Mehmet Doymaz2 and John Quale1,*

1 State University of New York—Downstate, Brooklyn, NY, USA 2 Beth Israel Medical Center, New York, NY, USA

Received 16 February 2007; returned 22 March 2007; revised 2 April 2007; accepted 5 April 2007


* Corresponding author. E-mail: jquale{at}downstate.edu

Objectives: To document resistance patterns of three important nosocomial pathogens, Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae, present in hospitals in Brooklyn, NY.

Methods: Susceptibility profiles of pathogens gathered during a surveillance study in 2006 were analysed and compared with similar surveys performed in 1999 and 2001. MICs were determined according to CLSI standards, and selected isolates were screened by PCR for the presence of VIM, IMP and KPC ß-lactamases.

Results: For P. aeruginosa, susceptibility to most antimicrobials fell in 2001 and then reached a plateau. However, there was a progressive decrease in the number of patients with P. aeruginosa during the three surveys. While the total number of isolates of A. baumannii remained steady, there was a progressive decrease in susceptibility to most classes of antimicrobial agents, and approximately one-third had combined resistance to carbapenems, fluoroquinolones and aminoglycosides. There was a noticeable rise in the number of isolates of K. pneumoniae over the surveillance periods, suggesting that this has become the predominant pathogen in many medical centres. Over one-third of K. pneumoniae collected in 2006 carried the carbapenemase KPC, and 22% were resistant to all three classes of antimicrobial agents.

Conclusions: Hospitals in our region have been beset with antimicrobial-resistant Gram-negative bacteria. K. pneumoniae has rapidly emerged as the most common multidrug-resistant pathogen. Improved therapeutic agents and methods of detection are needed to reduce transmission of these bacteria.

Key Words: P. aeruginosa , A. baumannii , K. pneumoniae


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
P. D. Lister, D. J. Wolter, and N. D. Hanson
Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Clin. Microbiol. Rev., October 1, 2009; 22(4): 582 - 610.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Baraniak, R. Izdebski, M. Herda, J. Fiett, W. Hryniewicz, M. Gniadkowski, I. Kern-Zdanowicz, K. Filczak, and U. Lopaciuk
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland
Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4565 - 4567.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
B. Kitchel, D. R. Sundin, and J. B. Patel
Regional Dissemination of KPC-Producing Klebsiella pneumoniae
Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4511 - 4513.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
D. Landman, S. Bratu, and J. Quale
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae
J. Med. Microbiol., October 1, 2009; 58(10): 1303 - 1308.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
S. Bratu, D. Landman, A. George, J. Salvani, and J. Quale
Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City
J. Antimicrob. Chemother., August 1, 2009; 64(2): 278 - 283.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
T. D. Gootz, M. K. Lescoe, F. Dib-Hajj, B. A. Dougherty, W. He, P. Della-Latta, and R. C. Huard
Genetic Organization of Transposase Regions Surrounding blaKPC Carbapenemase Genes on Plasmids from Klebsiella Strains Isolated in a New York City Hospital
Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1998 - 2004.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. Endimiani, A. M. Hujer, F. Perez, C. R. Bethel, K. M. Hujer, J. Kroeger, M. Oethinger, D. L. Paterson, M. D. Adams, M. R. Jacobs, et al.
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
J. Antimicrob. Chemother., March 1, 2009; 63(3): 427 - 437.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
J. Marschall, R. J. Tibbetts, W. M. Dunne Jr., J. G. Frye, V. J. Fraser, and D. K. Warren
Presence of the KPC Carbapenemase Gene in Enterobacteriaceae Causing Bacteremia and Its Correlation with In Vitro Carbapenem Susceptibility
J. Clin. Microbiol., January 1, 2009; 47(1): 239 - 241.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. M. Pillar, M. K. Torres, N. P. Brown, D. Shah, and D. F. Sahm
In Vitro Activity of Doripenem, a Carbapenem for the Treatment of Challenging Infections Caused by Gram-Negative Bacteria, against Recent Clinical Isolates from the United States
Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4388 - 4399.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. B. Rice, L. L. Carias, R. A. Hutton, S. D. Rudin, A. Endimiani, and R. A. Bonomo
The KQ Element, a Complex Genetic Region Conferring Transferable Resistance to Carbapenems, Aminoglycosides, and Fluoroquinolones in Klebsiella pneumoniae
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3427 - 3429.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Bratu, D. Landman, D. A. Martin, C. Georgescu, and J. Quale
Correlation of Antimicrobial Resistance with {beta}-Lactamases, the OmpA-Like Porin, and Efflux Pumps in Clinical Isolates of Acinetobacter baumannii Endemic to New York City
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 2999 - 3005.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
D. Landman, C. Georgescu, D. A. Martin, and J. Quale
Polymyxins Revisited
Clin. Microbiol. Rev., July 1, 2008; 21(3): 449 - 465.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
A. Y. Peleg, H. Seifert, and D. L. Paterson
Acinetobacter baumannii: Emergence of a Successful Pathogen
Clin. Microbiol. Rev., July 1, 2008; 21(3): 538 - 582.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
T. Naas, G. Cuzon, M.-V. Villegas, M.-F. Lartigue, J. P. Quinn, and P. Nordmann
Genetic Structures at the Origin of Acquisition of the {beta}-Lactamase blaKPC Gene
Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1257 - 1263.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. G. Giske, D. L. Monnet, O. Cars, Y. Carmeli, and on behalf of ReAct-Action on Antibiotic Resistance
Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli
Antimicrob. Agents Chemother., March 1, 2008; 52(3): 813 - 821.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.